SCHEMBL25752309

SCHEMBL25752309

CC1COC2=C1C(=O)C(=O)c1c2ccc2c1CCC[C@@]2(C)CO

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 7/20 0.75
▸ KMT2A Q03164 7/20 0.75
▸ ALDH1A1 P00352 6/20 0.75
▸ TDP1 Q9NUW8 5/20 0.75
▸ HIF1A Q16665 5/20 0.75
▸ EPAS1 Q99814 5/20 0.75
▸ CES2 O00748 5/20 0.75
▸ HPGD P15428 5/20 0.75
▸ HSD17B10 Q99714 5/20 0.75
▸ IDO1 P14902 5/20 0.75
▸ KDM4E B2RXH2 4/20 0.75
▸ MAPT P10636 4/20 0.75
▸ RECQL P46063 4/20 0.75
▸ CYP3A4 P08684 4/20 0.75
▸ BLM P54132 4/20 0.75
▸ CES1 P23141 4/20 0.75
▸ PTPN6 P29350 3/20 0.75
▸ PTPN11 Q06124 3/20 0.75
▸ ACHE P22303 3/20 0.75
▸ TDO2 P48775 3/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cryptotanshinone SCHEMBL29387944 0.86 MEN1 (1.00) MEN1KMT2AALDH1A1TDP1HIF1A
Cryptotanshinone SCHEMBL5940386 0.86 MEN1 (1.00) MEN1KMT2AALDH1A1TDP1HIF1A
Cryptotanshinone SCHEMBL4126834 0.86 MEN1 (1.00) MEN1KMT2AALDH1A1TDP1HIF1A
Cryptotanshinone SCHEMBL28181278 0.78 MEN1 (0.83) MEN1KMT2AALDH1A1TDP1HIF1A
SCHEMBL29405831 0.77 MEN1 (0.83) MEN1KMT2AALDH1A1TDP1HIF1A
Tanshinone Iib SCHEMBL14417728 0.76 EED (1.00) MEN1KMT2AALDH1A1TDP1HIF1A
Tanshinone Iib SCHEMBL11945767 0.76 EED (1.00) MEN1KMT2AALDH1A1TDP1HIF1A
SCHEMBL20457599 0.75 MEN1 (0.51) MEN1KMT2AALDH1A1TDP1HIF1A
SCHEMBL13883845 0.74 MEN1 (0.74) MEN1KMT2AALDH1A1TDP1HIF1A
Isotanshinone Iib SCHEMBL30381469 0.73 EED (0.85) MEN1KMT2AALDH1A1TDP1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212568-A1 MICRORNA-MEDIATED METHODS FOR REJUVENATING CNS GLIAL POPULATIONS UNIVERSITY OF ROCHESTER 2023-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212568-A1 MICRORNA-MEDIATED METHODS FOR REJUVENATING CNS GLIAL POPULATIONS MYT1, STAT3, MYC MEN1 2412/4885KMT2A 901/4885ALDH1A1 3434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback